Registration

ARENTFOX SCHIFF LLP for PHARVARIS PHARMACEUTICALS, INC. (FKA PHARVARIS, INC.)

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production

LobbyistCovered position, as disclosed
STARSHINE CHUN New Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023)
PHILIP ENGLISH New U.S. Representative (1995-2009)
LAURA EUGSTER DOYLE New Legislative Director, Rep. Philip English (1998-2002)
KELSEY GRISWOLD-BERGER New Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed
DANIEL SJOSTEDT New Staff Assistant, Rep. Jeff Fortenberry (2016-2017)
OLIVER SPURGEON III New Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)

Medicare/Medicaid MMM

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production

LobbyistCovered position, as disclosed
STARSHINE CHUN New Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023)
PHILIP ENGLISH New U.S. Representative (1995-2009)
LAURA EUGSTER DOYLE New Legislative Director, Rep. Philip English (1998-2002)
KELSEY GRISWOLD-BERGER New Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed
DANIEL SJOSTEDT New Staff Assistant, Rep. Jeff Fortenberry (2016-2017)
OLIVER SPURGEON III New Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)

Pharmacy PHA

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production

LobbyistCovered position, as disclosed
STARSHINE CHUN New Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023)
PHILIP ENGLISH New U.S. Representative (1995-2009)
LAURA EUGSTER DOYLE New Legislative Director, Rep. Philip English (1998-2002)
KELSEY GRISWOLD-BERGER New Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed
DANIEL SJOSTEDT New Staff Assistant, Rep. Jeff Fortenberry (2016-2017)
OLIVER SPURGEON III New Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)

Trade (domestic/foreign) TRD

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production

LobbyistCovered position, as disclosed
STARSHINE CHUN New Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023)
PHILIP ENGLISH New U.S. Representative (1995-2009)
LAURA EUGSTER DOYLE New Legislative Director, Rep. Philip English (1998-2002)
KELSEY GRISWOLD-BERGER New Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed
DANIEL SJOSTEDT New Staff Assistant, Rep. Jeff Fortenberry (2016-2017)
OLIVER SPURGEON III New Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
PHARVARIS N.V. Netherlands Netherlands 100.0% —
PHARVARIS GMBH Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.